학술논문
Impact and effectiveness of Rotavin-M1 under conditions of routine use in two provinces in Vietnam, 2016–2021, an observational and case–control study
Document Type
Article
Author
Van Trang, Nguyen; Tate, Jacqueline E.; Phuong Mai, Le Thi; Vu, Thiem Dinh; Quyet, Nguyen Tu; Thi Le, Ly Khanh; Thi Chu, Mai Ngoc; Ngoc Tran, Phuong Mai; Thi Pham, Thao Phuong; Nguyen, Huong Thuy; Nguyen, Hien Dang; Jiang, Baoming; Yen, Catherine; Tran, Duong Nhu; Anh, Dang Duc; Parashar, Umesh D.; Anh, Lai Tuan; Thanh, Vu Duc; Sanh, Le Van; Dieu Thuy, Dang Thi; Trang, Dinh Cong; Phong, Nguyen Quoc; Truong, Doan Hong; Tai, Tran Van; Dung, Phạm Van; Van, Do Van
Source
The Lancet Regional Health - Western Pacific; 20230101, Issue: Preprints
Subject
Language
ISSN
26666065
Abstract
Half of diarrhea hospitalizations in children aged <5 years in Vietnam are due to rotavirus. Following introduction of a locally developed and licensed oral rotavirus vaccine, Rotavin-M1, into the routine immunization program in two Vietnamese provinces, Nam Dinh and TT Hue, we describe changes in rotavirus positivity among children hospitalized for diarrhea and calculate vaccine effectiveness against moderate-to-severe rotavirus hospitalizations.